Doxofylline Acebrophylline dual action for COPD in Delhi NCR

Doxofylline 400mg Acebrophylline 100mg best for asthma in Mumbai Maharashtra

Doxofylline Acebrophylline combination fastest relief in Ahmedabad Gujarat

Doxofylline Acebrophylline Respiratory Tablet franchise in Lucknow UP

Doxofylline Acebrophylline effective for chronic bronchitis in Pune Maharashtra
Doxofylline Acebrophylline 400 100 high demand in Jaipur Rajasthan

Home/Products /doxofylline-400-mg-sr-acebrophylline-100-mg-tablet

Dozyfyle AB Tablet

Composition : Doxofylline (400mg) + Acebrophylline (100mg)

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹0/-

Please Contact For Best Price

Dozyfyle AB Tablet Doxofylline 400 mg Acebrophylline 100 mg is a premium respiratory combination offering both effective bronchodilation and mucolytic action. Doxofylline works as a xanthine derivative to relax the bronchial muscles while Acebrophylline provides additional bronchodilation and helps thin and clear mucus offering complete management for chronic conditions like COPD and bronchial asthma.

The synergistic dual molecule combination provides superior symptomatic relief leading to strong physician preference and predictable revenue. COPD and asthma require long term treatment guaranteeing stable high-volume sales.

The product is primarily prescribed by Pulmonologists and Consulting Physicians securing a high-value specialist segment. The single tablet form improves patient adherence. Secure your exclusive Dozyfyle AB territory and capitalize on the rapidly growing chronic respiratory management market.

Read More

About the Product

Dozyfyle AB Tablet Doxofylline 400 mg Acebrophylline 100 mg is a premium respiratory combination offering both effective bronchodilation and mucolytic action. Doxofylline works as a xanthine derivative to relax the bronchial muscles while Acebrophylline provides additional bronchodilation and helps thin and clear mucus offering complete management for chronic conditions like COPD and bronchial asthma.

The synergistic dual molecule combination provides superior symptomatic relief leading to strong physician preference and predictable revenue. COPD and asthma require long term treatment guaranteeing stable high-volume sales.

The product is primarily prescribed by Pulmonologists and Consulting Physicians securing a high-value specialist segment. The single tablet form improves patient adherence. Secure your exclusive Dozyfyle AB territory and capitalize on the rapidly growing chronic respiratory management market.

Common side effects may include nausea, vomiting, diarrhea, abdominal discomfort, or mild rash. Rarely, allergic reactions such as hives, swelling, or difficulty breathing may occur. Persistent or severe symptoms should prompt immediate medical consultation.

Moxyplit CV 457 Tablet is indicated for the treatment of bacterial infections, including respiratory tract infections (sinusitis, bronchitis, pneumonia), urinary tract infections, skin and soft tissue infections, otitis media, and dental infections. It is especially useful for infections caused by beta-lactamase-producing bacteria that are resistant to amoxicillin alone.

Take Moxyplit CV 457 Tablet exactly as prescribed by your healthcare provider. Disperse the tablet in a small amount of water before administration if required. Complete the full course of therapy even if symptoms improve early to prevent bacterial resistance. Patients allergic to penicillin or with a history of liver or kidney disorders should use this medication under strict medical supervision.

Store Moxyplit CV 457 Tablet in a cool, dry place below 25°C, protected from moisture and sunlight. Keep out of reach of children and discard any unused portion after the expiry date.

Get in Touch